Ad is loading...
RSLDX
Price
$69.58
Change
-$0.86 (-1.22%)
Updated
Nov 15 closing price
TAVFX
Price
$64.11
Change
+$0.10 (+0.16%)
Updated
Nov 15 closing price
Ad is loading...

RSLDX vs TAVFX

Header iconRSLDX vs TAVFX Comparison
Open Charts RSLDX vs TAVFXBanner chart's image
American Funds SMALLCAP World R5E
Price$69.58
Change-$0.86 (-1.22%)
VolumeN/A
CapitalizationN/A
Third Avenue Value Instl
Price$64.11
Change+$0.10 (+0.16%)
VolumeN/A
CapitalizationN/A
RSLDX vs TAVFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RSLDX vs. TAVFX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RSLDX is a Buy and TAVFX is a Sell.

FUNDAMENTALS
Fundamentals
RSLDX has more cash in the bank: 74.7B vs. TAVFX (733M). TAVFX pays higher dividends than RSLDX: TAVFX (2.17) vs RSLDX (0.83). RSLDX was incepted earlier than TAVFX: RSLDX (9 years) vs TAVFX (34 years). RSLDX is a more actively managed with annual turnover of: 29.00 vs. TAVFX (16.00). RSLDX has a lower initial minimum investment than TAVFX: RSLDX (250) vs TAVFX (10000). RSLDX annual gain was more profitable for investors over the last year : 16.23 vs. TAVFX (9.02). TAVFX return over 5 years is better than : 74.64 vs. RSLDX (20.19).
RSLDXTAVFXRSLDX / TAVFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years34 years-
Gain YTD3.928-0.666-590%
Front LoadN/AN/A-
Min. Initial Investment250100003%
Min. Initial Investment IRAN/AN/A-
Net Assets74.7B733M10,191%
Annual Yield % from dividends0.832.1738%
Returns for 1 year16.239.02180%
Returns for 3 years-25.4228.14-90%
Returns for 5 years20.1974.6427%
Returns for 10 yearsN/A28.12-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NSA43.130.80
+1.89%
National Storage Affiliates Trust
CISS1.110.02
+1.83%
C3is
UTI19.610.07
+0.36%
Universal Technical Institute
TXT84.91-1.19
-1.38%
Textron
HRTX1.19-0.05
-4.03%
Heron Therapeutics